Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mupirocin ointment to prevent nasal polyp recurrence after sinus surgery
IRCT20221013056165N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Mar 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of mupirocin in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Iran University of Medical Sciences. Started Mar 2020; status: completed.
02
Drugs
mupirocin
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on IRCT20221013056165N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221013056165N1.